

Can't find Zenzedi? Here are the best alternative ADHD medications to discuss with your doctor, including generic dextroamphetamine, Adderall, Vyvanse, and more.
If you've been struggling to find Zenzedi at your pharmacy, you're dealing with a frustration that thousands of patients share in 2026. The ongoing ADHD stimulant shortage has made brand-name Zenzedi one of the hardest medications to locate.
Pro tip: Before switching medications, try Medfinder to search for Zenzedi availability at pharmacies near you — you may find it closer than you think.
But if Zenzedi truly isn't available in your area, there are several effective alternatives worth discussing with your healthcare provider. Here's what you need to know about each one.
Zenzedi is the brand name for dextroamphetamine sulfate, an immediate-release CNS stimulant. It belongs to the amphetamine drug class and works by increasing levels of dopamine and norepinephrine in the brain — two neurotransmitters that play key roles in attention, focus, and impulse control.
Zenzedi is FDA-approved to treat ADHD in pediatric patients ages 3–16 and narcolepsy. It is also widely prescribed off-label for adult ADHD. As a Schedule II controlled substance, it is subject to strict DEA manufacturing quotas and prescribing regulations.
Zenzedi is manufactured by Azurity Pharmaceuticals and comes in immediate-release tablets in doses from 2.5 mg to 30 mg. Unlike Adderall, which contains a 3:1 mix of dextroamphetamine and levoamphetamine, Zenzedi is pure dextroamphetamine — which some patients find provides a cleaner, more focused effect with fewer side effects.
Dextroamphetamine, the active ingredient in Zenzedi, works by entering nerve terminals in the brain and triggering the release of dopamine and norepinephrine. It also blocks the reuptake of these neurotransmitters, keeping them active in the synaptic gap longer.
The result is improved focus, attention, and wakefulness. As an immediate-release formulation, Zenzedi typically takes effect within 30–60 minutes and lasts approximately 4–6 hours per dose. Most patients take it 2–3 times daily.
Because Zenzedi contains only the dextro-isomer of amphetamine (not the levo-isomer), it is more potent at dopamine receptor sites compared to mixed amphetamine products. This is why some patients specifically prefer Zenzedi or generic dextroamphetamine over Adderall. For a deeper dive, see our guide: How Does Zenzedi Work? Mechanism of Action Explained.
If you can't find Zenzedi, these are the most commonly considered alternatives. Always consult with your healthcare provider before making any changes to your medication.
This is the closest alternative to Zenzedi because it contains the exact same active ingredient — dextroamphetamine sulfate — in the same immediate-release tablet form. The only difference is the manufacturer and inactive ingredients (fillers, dyes, binders).
Adderall contains a combination of dextroamphetamine and levoamphetamine in a 3:1 ratio. It's available as both immediate-release (Adderall) and extended-release (Adderall XR) tablets.
Vyvanse is a prodrug of dextroamphetamine — meaning it converts to dextroamphetamine in your body after being absorbed. This creates a smoother onset and longer duration of action (up to 12–14 hours).
Methylphenidate is a different stimulant class from amphetamines. It works primarily by blocking the reuptake of dopamine and norepinephrine (rather than triggering their release like amphetamines do).
If you can't find Zenzedi, you have several effective alternatives to discuss with your prescriber:
Before switching, try Medfinder to search for Zenzedi in stock near you. And remember: never change your medication without consulting your healthcare provider.
For more information:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.